Inclisiran Effectiveness in China: a Pragmatic Randomized Trial | MicrobiomeTrials← Back to trialsNCT06941792
Inclisiran Effectiveness in China: a Pragmatic Randomized Trial
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2025-06-17Est. Completion: 2027-04-30
Enrollment target: 1,590 participants Locations- Novartis Investigative Site, Anqing, Anhui, China
- Novartis Investigative Site, Beijing, Beijing Municipality, China
- Novartis Investigative Site, Chongqing, Chongqing Municipality, China
- Novartis Investigative Site, Longyan, Fujian, China
- Novartis Investigative Site, Jiamusi, Heilongjiang, China
- Novartis Investigative Site, Zhengzhou, Henan, China
- Novartis Investigative Site, Baotou, Inner Mongolia, China
- Novartis Investigative Site, Shenyang, Liaoning, China
- Novartis Investigative Site, Shenyang, Liaoning, China
- Novartis Investigative Site, Jining, Shandong, China
- Novartis Investigative Site, Weifang, Shandong, China
- Novartis Investigative Site, Shanghai, Shanghai Municipality, China
- Novartis Investigated Site, Taiyuan, Shanxi, China
- Novartis Investigative Site, Chengdu, Sichuan, China
- Novartis Investigative Site, Ürümqi, Xinjiang Uygur Autonomous Region, China
- Novartis Investigative Site, Hangzhou, Zhejiang, China
- Novartis Investigative Site, Jinhua, Zhejiang, China
Other microbiome trials you might be interested in
Heart Failure
The purpose of this registry (NCT02880618) is to evaluate the effect of BAROSTIM THERAPY with the BAROSTIM NEO System in…
Hamburg, GermanyEst. completion Jul 2027
DermatomyositisPolymyositisInclusion Body Myositis
This study will evaluate subjects with adult- and childhood-onset myositis to learn more about their cause and the immun…
Atlanta, United States
Novartis Investigative Site, Ningbo, Zhejiang, ChinaNovartis Investigative Site, Wenzhou, Zhejiang, ChinaType II Endoleak
Abdominal Aortic Aneurysm Enlargement
Background and rationale:
Abdominal aortic aneurysm (AAA) is a weakening and enlargement of the main artery in the abdo…
Multiple LocationsEst. completion Dec 31, 2027